Silicon Valley tech companies are using COVID-19 blood samples of young people collected during donations for treatment trial to reverse the aging process. Billions of dollars were invested in geroscience months before the pandemic officially began.
Grifols, a Spanish firm set off a fuss in 2020 when it offered nearly double the going price for blood donations for treatment trial for covid-19.
Administrators at Brigham Young University's campus in southeastern Idaho said they were "de...
